Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Pharmaceutical

Health Bulletin 30/December/2022

admin by admin
December 30, 2022
in Pharmaceutical


Here are the top health news for the day:

India reports 268 new Covid-19 infections; active cases rise to 3,552

According to the Ministry of Health and Family Welfare data updated on Thursday, India recorded 268 new coronavirus infections, while the active caseload increased to 3,552

The data further informed that 220.08 crore total Vaccine doses (95.13 cr Second Dose and 22.39 cr Precaution Dose) have been administered so far under Nationwide Vaccination Drive.

“International passengers travelling from China, Hong Kong, Japan, South Korea, Singapore and Thailand to India will be mandatorily required to undergo RTPCR tests before their departure from these countries/destinations and upload the COVID negative RTPCR test report on Air Suvidha portal from 1st January 2023. The test should have been conducted within 72 hours of undertaking the journey to India,” Health Ministry stated.

Check out the Medical Dialogues official site for more health news:

https://medicaldialogues.in/

19 Eminent Doctors appointed to NMC, its various Boards

19 eminent doctors have been selected as part-time members of the medical advisory council of the National Medical Commission (NMC).

The Union Minister for Health and Family Welfare, Dr Mansukh Mandaviya took part in the appointment process through a draw of lots.

The procedure of appointments is laid down in National Medical Commission (NMC) Act, 2019.

All appointments comprised 10 Part-time Members from State/UT governments, 9 Part-time Members from State Medical Council, fourth Member of each Autonomous Board and One expert for Search Committee.

For more details, check out the link given below:

19 Eminent Doctors Appointed To NMC, Its Various Boards

An effective obesity drug has now been approved for teens

The Food and Drug Administration (FDA) has recently expanded the eligibility of Novo Nordisk’s Wegovy, a medication indicated for the treatment of obesity in children as young as 12.

Wegovy is a prescription medicine indicated for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight-related medical problems to help them lose weight and keep it off used with a reduced-calorie meal plan and increased physical activity.

Check out the Medical Dialogues official site for more health news:

https://medicaldialogues.in/



Source link

Tags: coronaviruscoronavirus casescovid-19Dr Mansukh MandaviyafdaNational Medical CommissionNMCNMC act 2019NMC boardNovo NordiskNovo Nordisk newsobesityobesity drugwegovy
Previous Post

The ‘fourth wave’ of the overdose crisis

Next Post

How Systolic BP Modulates LVEF Impact on Acute MI Outcomes

Next Post

How Systolic BP Modulates LVEF Impact on Acute MI Outcomes

Recommended

CDC Prompts Wendy’s To Remove Lettuce From Sandwiches

August 20, 2022

FDA scolds Sun Pharma for allegedly backdating documents- STAT

August 21, 2022

Don't miss it

Pharmaceutical

Strange bedfellows lobby for Medicare obesity-drug coverage

January 26, 2023
Medicines & Healthy Lifestyle

FDA Panel Votes on Rezafungin for Treatment of Candidemia, Invasive Candidiasis

January 26, 2023
Medicines & Healthy Lifestyle

This Cancer Drug Can Increase Longevity, Study Finds

January 26, 2023
News

Something in Breast Milk Helps Protect Babies Against Allergies

January 26, 2023
Pharmaceutical

Merck ends late-stage trial for Keytruda in prostate cancer

January 25, 2023
Medicines & Healthy Lifestyle

Are Seed Oils Behind the Majority of Diseases This Century?

January 25, 2023

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.